By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199




GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.

Company News
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014 11:35:40 AM
Johnson & Johnson (JNJ), Medivir AB (MVRBF) Snags U.S. Approval For Hepatitis C Combo With Gilead Sciences, Inc. (GILD) 11/6/2014 6:10:50 AM
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C 10/30/2014 9:55:10 AM
Notice Of Extraordinary General Meeting Of Medivir AB (MVRBF) (Publ) 10/23/2014 11:55:35 AM
Medivir AB (MVRBF): Optimization Of Capital Structure 10/16/2014 1:53:36 PM
Medivir AB (MVRBF): Phase 2 IMPACT Study Initiated To Evaluate Simeprevir In Combination With Sofosbuvir And Daclatasvir To Treat Genotype 1 And 4 Hepatitis C Patients 10/10/2014 8:33:57 AM
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014 1:28:50 PM
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014 8:32:57 AM
Ex-Merck & Co., Inc. (MRK) Exec Appointed New President And CEO Of Medivir AB (MVRBF) 8/11/2014 6:15:44 AM
Medivir AB (MVRBF) Licenses Respiratory Syncytial Virus Drug Program From Boehringer Ingelheim Corporation 8/4/2014 11:04:25 AM